Cancer Immunotherapy: Why Some High-Fat Diets Improved

What did researchers discover about diet and cancer immunotherapy?

A study published in Nature explored a puzzling observation: although obesity carries health risks, some studies have associated higher body mass index with better responses to immune checkpoint inhibitors. Researchers compared 12 mouse diets to investigate the biology behind this pattern. Some diets associated with weight gain improved treatment responses, including after relatively short exposure. [McGill research report](https://healthenews.mcgill.ca/focusing-on-the-obesity-paradox-to-improve-cancer-treatment-success/)

The findings suggest that body weight alone is an incomplete explanation. Diet and the microbial community in the gut appeared to interact in ways that influenced treatment effectiveness. The researchers explicitly cautioned against interpreting the results as a reason for people with cancer to adopt unhealthy diets. [McGill research report](https://healthenews.mcgill.ca/focusing-on-the-obesity-paradox-to-improve-cancer-treatment-success/)

How could gut bacteria change the effects of immunotherapy drugs?

Checkpoint inhibitors block signals that can prevent immune cells called T cells from attacking cancer. Medicines targeting PD-1, PD-L1 or CTLA-4 are established examples. Because these drugs depend on immune activity, understanding the factors that influence that activity could help researchers develop treatment combinations. [National Cancer Institute explanation](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors)

In the mouse experiments, the bacterium Lactobacillus johnsonii acted together with an obesity-promoting diet to support tumor regression, accompanied by enrichment of microbial metabolites derived from aromatic amino acids. Experiments transferring human donor gut microbes into mice also influenced treatment responses. These remained animal experiments; using human donor material did not make them clinical trials. [Original Nature study](https://www.nature.com/articles/s41586-026-10750-x)

Could these findings lead to better cancer treatments?

A possible research direction is to identify specific microbial products or combinations of bacteria and nutrients that reproduce the favorable response. This is a proposed implication of the findings, not an established therapy. Clinical development would need to determine whether such interventions improve meaningful patient outcomes and whether they change treatment toxicity. The mouse study cannot establish those benefits or risks. [Original Nature study](https://www.nature.com/articles/s41586-026-10750-x)

For patients receiving treatment now, nutrition should reflect their individual needs. The National Cancer Institute notes that some people with cancer need additional calories and protein to maintain strength and prevent malnutrition. An oncology dietitian can help address appetite loss, weight changes and eating difficulties. Such nutritional support serves a different purpose from deliberately changing diet to alter immunotherapy response. [National Cancer Institute nutrition guidance](https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition)